GlassScriptPhysician profile
Laura Jean Brewster
NPI 1124463641
$6,614.80
in general payments reported to CMS, 2019-2025
14 companies · $1,745 in 2025
The $1,745 reported for 2025 was more than what 90% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,135 · 2022: $878 · 2023: $1,491 · 2024: $1,366 · 2025: $1,745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,601.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,954.12 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,714.42 | 2021-2025 | Caplyta |
| Corium, LLC | $649.32 | 2022-2025 | Azstarys, Azstarys |
| Axsome Therapeutics, INC. | $423.79 | 2023-2025 | Auvelity |
| Supernus Pharmaceuticals, INC. | $390.05 | 2021-2025 | Qelbree, Qelbree |
| Lundbeck LLC | $338.97 | 2021-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $246.45 | 2021-2024 | Rexulti, Abilify Maintena |
| Alkermes, INC. | $215.00 | 2023-2024 | Aristada, Aristada Initio, Lybalvi |
| Collegium Pharmaceutical, INC. | $186.06 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $134.95 | 2021 | |
| Ironshore Pharmaceuticals INC. | $131.65 | 2023-2024 | Jornay Pm |
| Tris Pharma INC | $110.97 | 2023-2025 | Dyanavel Xr, Onyda Xr |
| Sunovion Pharmaceuticals INC. | $89.71 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $29.34 | 2024 | Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Jean Brewster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.